ZA929867B - New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs - Google Patents

New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs

Info

Publication number
ZA929867B
ZA929867B ZA929867A ZA929867A ZA929867B ZA 929867 B ZA929867 B ZA 929867B ZA 929867 A ZA929867 A ZA 929867A ZA 929867 A ZA929867 A ZA 929867A ZA 929867 B ZA929867 B ZA 929867B
Authority
ZA
South Africa
Prior art keywords
hypolipidemic
ether compounds
new
antiatherosclerotic drugs
antiatherosclerotic
Prior art date
Application number
ZA929867A
Other languages
English (en)
Inventor
Markus R Gold
Panayiotis Jarglis
Heinz Junglas
Juergen H Leimner
Dezsoe Peteri
Guenter P Quack
Josef Strohmeier
Petra M Wulfroth
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of ZA929867B publication Critical patent/ZA929867B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA929867A 1991-12-19 1992-12-18 New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs ZA929867B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/810,214 US5254549A (en) 1991-12-19 1991-12-19 New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs

Publications (1)

Publication Number Publication Date
ZA929867B true ZA929867B (en) 1994-06-20

Family

ID=25203281

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA929867A ZA929867B (en) 1991-12-19 1992-12-18 New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs

Country Status (16)

Country Link
US (1) US5254549A (xx)
EP (1) EP0619807A1 (xx)
JP (1) JPH07502271A (xx)
AU (1) AU662193B2 (xx)
CA (1) CA2085687A1 (xx)
CZ (1) CZ283456B6 (xx)
FI (1) FI942908A0 (xx)
HU (1) HU215844B (xx)
IL (1) IL104123A (xx)
MX (1) MX9207427A (xx)
NO (1) NO301473B1 (xx)
PL (1) PL171225B1 (xx)
RU (1) RU2120938C1 (xx)
TW (1) TW221289B (xx)
WO (1) WO1993012089A1 (xx)
ZA (1) ZA929867B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US5627172A (en) * 1994-03-04 1997-05-06 Natural Supplement Association, Incorporated Method for reduction of serum blood lipids or lipoprotein fraction
US5608095A (en) * 1996-04-30 1997-03-04 Hoechst Marion Roussel, Inc. Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
US5795876A (en) * 1996-04-30 1998-08-18 Hoechst Marion Rousssel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents
US6121463A (en) * 1997-06-24 2000-09-19 Hoechst Marion Roussel, Inc. Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
US6475526B1 (en) 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
US20080274209A1 (en) * 2002-11-04 2008-11-06 Integritas Pharma, Inc. Methods of treating inflammation
US6855341B2 (en) * 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE271625C (xx) *
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives
DE3431004A1 (de) * 1984-08-23 1986-03-06 Hoechst Ag, 6230 Frankfurt Neue 3-pyridylverbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
MX9207427A (es) 1993-11-01
NO942307D0 (no) 1994-06-17
PL171225B1 (pl) 1997-03-28
FI942908A (fi) 1994-06-17
IL104123A (en) 1996-12-05
FI942908A0 (fi) 1994-06-17
AU662193B2 (en) 1995-08-24
JPH07502271A (ja) 1995-03-09
CZ135294A3 (en) 1995-11-15
HU215844B (hu) 1999-04-28
US5254549A (en) 1993-10-19
NO942307L (no) 1994-06-17
TW221289B (xx) 1994-02-21
AU3159293A (en) 1993-07-19
HU9401820D0 (en) 1994-09-28
CZ283456B6 (cs) 1998-04-15
IL104123A0 (en) 1993-05-13
EP0619807A1 (en) 1994-10-19
RU2120938C1 (ru) 1998-10-27
CA2085687A1 (en) 1993-06-20
NO301473B1 (no) 1997-11-03
WO1993012089A1 (en) 1993-06-24
HUT70398A (en) 1995-10-30

Similar Documents

Publication Publication Date Title
EP0526824A3 (en) Syringe sprayer
ZA92913B (en) New beta-amino-alpha hydroxycarboxylic acids and ttheir use
EP0785806A4 (en) DISPOSABLE SYRINGE
SG46569A1 (en) Improved tubular bandage
GB2256146B (en) Syringe
IL104123A0 (en) New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
EP0511152A3 (en) Quinoxaline compounds, their preparation and use
LTIP399A (en) New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances
AU1740692A (en) New medicinal use
IL101880A0 (en) Arylaminocarbonyl compounds,their preparation and their use as herbicides
GB9123204D0 (en) New pharmaceutical use
GB9113943D0 (en) New pharmaceutical use
GB9123202D0 (en) New pharmaceutical use
GB9104269D0 (en) New pharmaceutical use
GB9104307D0 (en) New pharmaceutical use
GB9104306D0 (en) New pharmaceutical use
GB9113918D0 (en) New pharmaceutical use
GB9113850D0 (en) New pharmaceutical use
GB9108749D0 (en) New medical use
GB9104753D0 (en) New medical use
GB9104825D0 (en) New medical use
GB9204390D0 (en) New pharmaceutical use
GB9204587D0 (en) New pharmaceutical use
GB9023637D0 (en) New pharmaceutical use